Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | FLT3 | P36888 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | DAO | P14920 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.47 |
| ▸ | DDO | Q99489 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29631691 | 0.74 | RAB9A (0.74) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL374022 | 0.74 | RAB9A (0.74) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL29377234 | 0.72 | AOC3 (0.56) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL4417665 | 0.70 | AOC3 (0.54) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL223071 | 0.70 | AOC3 (0.54) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL5395 | 0.70 | AOC3 (0.54) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL261138 | 0.70 | AOC3 (0.54) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL980499 | 0.70 | AOC3 (0.54) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL37667 | 0.70 | AOC3 (1.00) | AOC3NPC1RAB9ALOXL2FLT3 | |
| SCHEMBL1388385 | 0.70 | AOC3 (0.54) | AOC3NPC1RAB9ALOXL2FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11986507-B1 | Micronutrient composition to improve men's health | Rath, Matthias W. (US) | 2024-05-21 | — | — | US | claimed |
| CN-113093317-B | Near-infrared ray absorption substrate and optical device including the same | 株式会社LMS | 2023-04-18 | — | — | CN | claimed |
| CN-111108414-B | Optical article and optical filter comprising the same | 株式会社LMS | 2022-02-01 | — | — | CN | claimed |
| CN-109416420-B | Optical product and optical filter thereof | 株式会社LMS | 2021-09-07 | — | — | CN | claimed |
| CN-110462462-B | Optical article and optical filter comprising the same | 株式会社LMS | 2021-07-30 | — | — | CN | claimed |
| CN-113093317-A | Near-infrared absorbing substrate and optical device including the same | 株式会社LMS | 2021-07-09 | — | — | CN | claimed |
| US-10908081-B2 | Optical article and optical filter including same | LMS CO., LTD (KR) | 2021-02-02 | — | — | US | claimed |
| US-10767030-B2 | Optical article and optical filter comprising same | LMS CO., LTD. | 2020-09-08 | — | — | US | claimed |
| CN-111108414-A | Optical article and optical filter comprising the same | 株式会社LMS | 2020-05-05 | — | — | CN | claimed |
| US-20200072741-A1 | OPTICAL ARTICLE AND OPTICAL FILTER INCLUDING SAME | LMS CO., LTD (KR) | 2020-03-05 | — | — | US | claimed |
| WO-2007017423-A2 | PHARMACEUTICAL COMPOSITION COMPRISING A DPP-IV INHIBITOR | F. HOFFMANN-LA ROCHE AG (CH) | 2007-02-15 | — | — | WO | claimed |
| US-20050096348-A1 | DPP IV inhibitors | BOEHRINGER MARKUS (CH) | 2005-05-05 | — | — | US | claimed |
| EP-1441719-A1 | N-SUBSTITUTED PYRROLIDIN DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-08-04 | — | — | EP | claimed |
| US-6656910-B2 | Serine protease inhibitors | CORTECH, INC. | 2003-12-02 | — | — | US | claimed |
| US-20030130281-A1 | DPP IV inhibitors | HOFFMAN-LA ROCHE INC. | 2003-07-10 | — | — | US | claimed |
| WO-2003037327-A1 | N-SUBSTITUTED PYRROLIDIN DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS | F. HOFFMANN-LA-ROCHE AG (CH) | 2003-05-08 | — | — | WO | claimed |
| US-20030060418-A1 | Serine protease inhibitors | CORTECH, INC. | 2003-03-27 | — | — | US | claimed |
| US-5798337-A | USED TO PROMOTE GROWTH IN MAMMALS EITHER ALONE OR IN COMBINATION WITH OTHER GROWTH PROMOTING COMPOUNDS | GENENTECH, INC. (US) | 1998-08-25 | — | — | US | claimed |
| WO-1997009333-A1 | NOVEL THIO-PHOSPHOORGANIC COMPOUNDS WITH PLANT PROTECTING ACTIVITY | SITRA FOUNDATION (FI) | 1997-03-13 | — | — | WO | claimed |
| US-4500467-A | ANGIOTENSIN INHIBITORS, HYPOTENSIVE AGENTS | BASF AKTIENGESELLSCAFT (DE) | 1985-02-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030060418-A1 | Serine protease inhibitors | PRSS1, SERPINB1, SERPINE1 | AOC3 2799/4885NPC1 4186/4885RAB9A 4168/4885 |
| US-20030130281-A1 | DPP IV inhibitors | DPP4, DPP3, DPP7 | AOC3 4273/4885NPC1 591/4885RAB9A 3016/4885 |
| US-20050096348-A1 | DPP IV inhibitors | DPP4, DPP3, DPP7 | AOC3 3799/4885NPC1 801/4885RAB9A 3061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.